Whitehawk Therapeutics

Akari Therapeutics and Whitehawk Expand Dual-Payload ADC Strategy

Tampa, Florida and London, United Kingdom — August 13, 2026 Akari Therapeutics, Plc reported progress on its lead antibody-drug...

By cGxPwire Editor
August 15, 2026

Bio-Pharma

Akari and Whitehawk Launch ADC Research Partnership

Tampa, Florida, USA & London, UK | July 21, 2026 Akari Therapeutics announced a strategic research collaboration with Whitehawk...

By cGxPwire Editor
July 22, 2026

Bio-Pharma

Biocytogen Partners Whitehawk on BsADC Cancer Therapies

BOSTON and MORRISTOWN, N.J., July 7, 2026 Biocytogen and Whitehawk Therapeutics have announced a global strategic collaboration to accelerate...

By cGxPwire Editor
July 10, 2026

Bio-Pharma

Whitehawk Highlights SEZ6 as Promising ADC Target in SCLC at ASCO 2026

MORRISTOWN, N.J., May 30, 2026 Whitehawk Therapeutics announced new real-world data at the 2026 American Society of Clinical Oncology...

By cGxPwire Editor
June 1, 2026

Bio-Pharma